Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 22, 2002
[Binding of G alpha o N-terminus is responsible for the voltage-resistant inhibition of alpha 1A (P/Q-type, Cav2.1) Ca2+ channels]Mariko Kinoshita
Analytical Chemistry|August 17, 2018
Kinetic Study of Chiral Intermolecular Interactions by Moment Analysis Based on Affinity Capillary ElectrophoresisNozomu Suzuki, Mariko Kinoshita, Kanji Miyabe
ACS Omega|December 8, 2025
Evaluation of the Valence Band Maximum of Hematite Particles Dispersed in Aqueous Solution: An Approach Using Photoemission Yield Spectroscopy in AirMariko Kinoshita, Sayaka Yanagida, Shoichi Somekawa
Brain Research. Molecular Brain Research|November 19, 2004
A Purkinje cell specific GoLoco domain protein, L7/Pcp-2, modulates receptor-mediated inhibition of Cav2.1 Ca2+ channels in a dose-dependent mannerMariko Kinoshita-Kawada, John Oberdick, Michael Xi Zhu
Journal of Pediatric Hematology/Oncology|May 31, 2021
A Metastatic Neuroblastic Tumor in a 28-Month-old Boy: Unusual Spontaneous Regression From Neuroblastoma to Ganglioneuroma?Ai Yamada, Mariko Kinoshita, Sachiyo Kamimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migrationJunichi Yuasa-Kawada, Mariko Kinoshita-Kawada, Yi Rao, et al.
Protein & Cell|March 21, 2023
Neuronal guidance genes in health and diseasesJunichi Yuasa-Kawada, Mariko Kinoshita-Kawada, Yoshio Tsuboi, et al.
Pediatric Blood & Cancer|August 24, 2017
Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapyMariko Kinoshita, Ai Yamada, Daisuke Sawa, et al.
Nature Neuroscience|August 18, 2009
Midline crossing and Slit responsiveness of commissural axons require USP33Junichi Yuasa-Kawada, Mariko Kinoshita-Kawada, Guan Wu, et al.
Cancers|September 28, 2021
Development and Validation of an HPLC Method for Analysis of Topotecan in Human Cerebrospinal Fluid and Its Application in Elimination Evaluation of Topotecan after Intraventricular InjectionNaoki Yoshikawa, Ai Yamada, Tsubasa Yokota, et al.
Pageof 4